160 related articles for article (PubMed ID: 2895504)
1. [Biological psychiatry. 1) The dopamine-acetylcholine equilibrium model].
Adèr JP
TVZ; 1988 Jan; 42(1):13-6. PubMed ID: 2895504
[No Abstract] [Full Text] [Related]
2. Neurotransmitter interactions related to central dopamine neurons.
Lloyd KG
Essays Neurochem Neuropharmacol; 1978; 3():129-207. PubMed ID: 30628
[No Abstract] [Full Text] [Related]
3. Biochemical substrates of mental disturbances in Parkinson's disease.
Agid Y; Ruberg M; Dubois B; Javoy-Agid F
Adv Neurol; 1984; 40():211-8. PubMed ID: 6695597
[No Abstract] [Full Text] [Related]
4. The biochemistry of affective disorders.
Eccleston D
Br J Hosp Med; 1982 Jun; 27(6):627-30. PubMed ID: 6180790
[No Abstract] [Full Text] [Related]
5. [Problems and future perspectives in the treatment of Parkinson's disease].
Hens L; Hellemans J
Tijdschr Gerontol Geriatr; 1982 Aug; 13(4):147-54. PubMed ID: 6127822
[TBL] [Abstract][Full Text] [Related]
6. Metabolic products of arachidonic acid in the central nervous system: possible role in mental disorders.
Mathé AA; Apéria B; Bergman P; Eberhard G; Jerling M; Lindström L; Sääf J; Undén F; Wetterberg L
Adv Prostaglandin Thromboxane Leukot Res; 1987; 17B():958-62. PubMed ID: 2960211
[No Abstract] [Full Text] [Related]
7. [Old and new thought concepts on the biochemical principles of psychopharmcotherapy].
Wunderlich H; Wunderlich HP
Samml Zwangl Abh Geb Psychiatr Neurol; 1982; 50():61-80. PubMed ID: 6130615
[No Abstract] [Full Text] [Related]
8. Endocannabinoid lipids and mediated system: implications for alcoholism and neuropsychiatric disorders.
Vinod KY; Hungund BL
Life Sci; 2005 Aug; 77(14):1569-83. PubMed ID: 16005471
[TBL] [Abstract][Full Text] [Related]
9. [The probenecid test. Evaluation in clinical medicine of cerebral metabolism of serotonin and dopamine].
Véron JP; Mérienne L
Nouv Presse Med; 1972 Feb; 1(8):537-9. PubMed ID: 4258943
[No Abstract] [Full Text] [Related]
10. The impact of scientific models on clinical psychopharmacology: a psychiatrist's view.
Cole JO
Semin Psychiatry; 1972 Aug; 4(3):261-4. PubMed ID: 4680224
[No Abstract] [Full Text] [Related]
11. Mechanisms of Parkinson's disease.
Br Med J; 1978 Apr; 1(6117):872-3. PubMed ID: 25109
[No Abstract] [Full Text] [Related]
12. [Electrolyte changes and mental disorders].
Villani F; Andreoli V; Mangoni A
Riv Sper Freniatr Med Leg Alien Ment; 1972 Feb; 96(1):7-31. PubMed ID: 4337777
[No Abstract] [Full Text] [Related]
13. [Parkinson disease and the neuronal dopamine uptake complex].
Costentin J
Ann Pharm Fr; 1995; 53(4):145-54. PubMed ID: 7574268
[TBL] [Abstract][Full Text] [Related]
14. Volume transmission.
Ridet I; Privat A
Trends Neurosci; 2000 Feb; 23(2):58-9. PubMed ID: 10652543
[No Abstract] [Full Text] [Related]
15. [The future of biological psychiatry].
Linnoila M
Duodecim; 1985; 101(17):1732-7. PubMed ID: 2865128
[No Abstract] [Full Text] [Related]
16. The probenecid test.
Korczyn AD
J Neural Transm Suppl; 1983; 19():173-83. PubMed ID: 6142088
[TBL] [Abstract][Full Text] [Related]
17. Neurotransmitter systems in schizophrenia.
Reynolds GP
Int Rev Neurobiol; 1995; 38():305-39. PubMed ID: 8537203
[No Abstract] [Full Text] [Related]
18. A Markov process based model of the neurotransmitter-receptor binding process in the brain.
Elkarmi AZ; Karmi MZ; Alkarmi ZM
Drug Des Deliv; 1988 Jul; 3(1):69-76. PubMed ID: 2908226
[TBL] [Abstract][Full Text] [Related]
19. Brain amines and peptides--their relevance to psychiatry.
Smith GC; Copolov D
Aust N Z J Psychiatry; 1979 Dec; 13(4):283-91. PubMed ID: 44187
[TBL] [Abstract][Full Text] [Related]
20. Catecholamines in neuropsychiatric states.
Kety SS
Pharmacol Rev; 1966 Mar; 18(1):787-98. PubMed ID: 5323770
[No Abstract] [Full Text] [Related]
[Next] [New Search]
